Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Yes, the MMSE frequently produces false positive results—sometimes alarmingly so. The Mini-Mental State Examination, one of the most widely used cognitive screening tools, can incorrectly suggest dementia or cognitive impairment in people who do not actually have these conditions. In a primary care setting using the standard cutoff score of 24, the test has a positive predictive value of only 52%, meaning that about half of people who screen positive on the MMSE do not actually have dementia. Even more striking: in a study of French elderly community residents, 85% of subjects who tested positive for dementia using the MMSE cutoff of 24 were false positives—they did not have dementia at all.
The reason for these high false-positive rates lies in how the MMSE was originally designed and validated. It was created in 1975 as a brief bedside tool, not as a definitive diagnostic instrument. Yet for decades, clinicians and primary care providers have used it as though it could reliably identify who has dementia and who does not. The test’s simplicity and speed made it popular, but this convenience came at a cost: reliability varies dramatically depending on where it is used, who takes it, and how strictly the cutoff score is applied.
Table of Contents
- Why Does MMSE Produce So Many False Positives in Primary Care?
- False-Positive Rates Across Different Populations
- How Demographics Skew MMSE Results and Create False Positives
- The Problem of Cutoff Scores and When to Apply Them
- Why MMSE Misses Mild Cognitive Impairment and Creates Both False Positives and Negatives
- What to Do If MMSE Suggests Impairment: Moving Forward With Appropriate Testing
- Beyond the MMSE—The Shift Toward More Accurate Screening Tools
- Conclusion
- Frequently Asked Questions
Why Does MMSE Produce So Many False Positives in Primary Care?
The mmse‘s false-positive problem is particularly acute in primary care settings. When a primary care physician administers the MMSE to an older patient, the test identifies “cognitive impairment” in many people who are actually cognitively normal. This happens partly because primary care populations are broader and more diverse than the specialized dementia clinics where the MMSE was originally validated. People in primary care include many without memory complaints, without cognitive symptoms, and without any family history of dementia—yet the MMSE still flags them as potentially impaired.
The diagnostic accuracy of the MMSE shifts dramatically by clinical setting. In memory clinic settings, where patients have already been referred specifically because of memory concerns, the MMSE has a sensitivity of 79.8% and specificity of 81.3%. In contrast, in mixed specialist hospital settings with different patient populations, sensitivity drops to 71.1% while specificity rises to 95.6%. These differences tell us something important: the same test, with the same cutoff score, works very differently depending on whether you are screening a general population or evaluating someone already suspected of having cognitive problems. In primary care—the most common setting where the MMSE is used—the diagnostic accuracy tends toward the lower end, making false positives more likely.

False-Positive Rates Across Different Populations
Population-level data on MMSE false positives reveals stark variations. A meta-analysis of MMSE accuracy in community and primary care populations found pooled sensitivity of 0.85 (95% CI 0.74–0.92) and specificity of 0.90 (95% CI 0.82–0.95), which sounds reasonably good—but those numbers mask a serious problem. A specificity of 90% means that 10% of people without dementia will test positive on the MMSE. In a primary care practice screening 100 cognitively normal older adults, ten will receive false positive results, potentially triggering unnecessary follow-up testing, specialist referrals, and patient anxiety. The French elderly study mentioned earlier is particularly instructive because it illustrates what happens when you apply MMSE in a real-world community setting.
Among elderly residents who screened positive using the MMSE cutoff of 24, the test showed 100% sensitivity (it caught all true cases of dementia) but only 78% specificity. The positive predictive value—the percentage of positive tests that actually indicate dementia—was just 15%. This means that 85 out of 100 people who tested positive did not have dementia. They were false positives. In practical terms, if an elderly person in the community takes the MMSE and scores below 24, there is roughly an 85% chance they do not have dementia at all, assuming they come from a typical community population without pre-existing cognitive complaints.
How Demographics Skew MMSE Results and Create False Positives
One of the most significant sources of MMSE false positives is demographic variation. The test assumes a baseline level of education, literacy, and familiarity with American culture and language. People with limited formal education, lower literacy levels, or for whom English is a second language often score lower on the MMSE, not because their cognition is impaired, but because the test is biased toward their specific disadvantage. Age also influences MMSE performance independently of actual cognitive status.
An 85-year-old may score lower than a 65-year-old on the MMSE simply due to normal aging effects on processing speed and memory, without having any disease process. Research shows that education and age adjustments can reduce false-positive rates in elderly and less-educated populations. Some clinicians now use age and education correction scores—adding points back to the raw MMSE score based on the person’s education and age—to account for these demographic effects. However, many primary care settings do not routinely apply these adjustments, meaning that patients who are older or less educated are at higher risk for a false positive result. A person with a ninth-grade education who otherwise has normal cognition might score 22 on the MMSE and be incorrectly classified as cognitively impaired, simply because the test did not account for educational background.

The Problem of Cutoff Scores and When to Apply Them
The MMSE’s false-positive problem is intimately tied to where you draw the line. The standard cutoff of 24 (scores below 24 are considered abnormal) is not universally appropriate. Different cutoff scores can be chosen for different populations, but this flexibility also creates confusion. Some research suggests that for highly educated people, a cutoff of 25 or 26 might be more appropriate, while for less-educated people, a cutoff of 18 or 20 might better reflect actual cognitive impairment. The trade-off is stark: lower cutoff scores catch fewer false positives but may miss some real cases of mild dementia; higher cutoff scores catch more real cases but generate more false positives.
This is why the positive predictive value is such a critical number to understand. The positive predictive value depends not just on the test itself, but on the prevalence of dementia in the population being screened. When you screen a community population where only 5-10% actually have dementia, a positive MMSE result is much more likely to be a false positive. When you screen a memory clinic population where 50-70% of patients have dementia, a positive result is much more likely to be a true positive. The same test, same score, same cutoff—but vastly different meaning depending on context. Many patients and families do not understand this, and assume that a positive MMSE result means dementia has been diagnosed, when in fact it only means further evaluation is needed.
Why MMSE Misses Mild Cognitive Impairment and Creates Both False Positives and Negatives
The MMSE is particularly unreliable when it comes to mild cognitive impairment (MCI)—the stage where cognitive decline is evident but does not meet the threshold for dementia diagnosis. Because the MMSE is relatively insensitive to mild cognitive changes, it can produce false negatives (missing people with early MCI) or false positives (identifying MCI-like patterns in normal aging or in people with other conditions like depression or anxiety). A person in early MCI might score 26 or 27 on the MMSE—in the “normal” range—when more sophisticated testing would reveal measurable decline. Conversely, a person with depression or anxiety might score poorly on MMSE because of attentional problems or motivation, receiving a false positive classification of cognitive impairment when the real issue is mood.
This limitation is particularly important because mild cognitive impairment is increasingly recognized as a critical intervention window. If the MMSE misses MCI, patients may not receive early treatment, cognitive training, or lifestyle modifications that could slow decline. If the MMSE falsely identifies MCI, patients may receive unnecessary medications, specialist referrals, and psychological burden from a misdiagnosis. The take-away is that a single MMSE score should never be the sole basis for any cognitive diagnosis. The test is a brief screening tool, useful as a starting point or for tracking change over time in a known patient, but not sufficient for diagnostic purposes on its own.

What to Do If MMSE Suggests Impairment: Moving Forward With Appropriate Testing
If you or a loved one receives a concerning MMSE score, the appropriate next step is not to assume dementia has been found, but to pursue more comprehensive cognitive evaluation. Neuropsychological testing, while more time-consuming and expensive than the MMSE, is far more sensitive and specific for identifying actual cognitive impairment and determining its cause. A neuropsychological battery tests memory, language, executive function, processing speed, and other domains in detail, and includes tests designed to distinguish dementia from depression, anxiety, normal aging, or other conditions that can mimic cognitive impairment.
Additionally, the clinical context matters enormously. A physician should ask: Does the patient have cognitive complaints? Does a collateral source (spouse, family member) report actual memory loss or functional decline in daily activities? Are there objective changes in the patient’s behavior or abilities that others have noticed? An MMSE score of 23 is much more concerning if the patient’s spouse reports that he is getting lost driving to familiar places and forgetting to take medications, than if the patient has no complaints and the spouse reports no changes. A comprehensive evaluation integrates the MMSE result with clinical history, informant interview, imaging, laboratory tests, and other assessments to arrive at a more reliable conclusion.
Beyond the MMSE—The Shift Toward More Accurate Screening Tools
The limitations of the MMSE are increasingly recognized in modern dementia care, and many clinical settings are moving toward alternative or supplementary screening tools. The Montreal Cognitive Assessment (MoCA), for example, is more sensitive to mild cognitive changes and includes more challenging items designed to detect early impairment. The Addenbrooke’s Cognitive Examination (ACE) is another option. Some primary care settings are also implementing more detailed questionnaires like the Cognitive Complaints in Aging (Cognitive Complaints Scale) or the memory impairment screen, which ask about functional decline rather than just cognitive performance.
No single test is perfect, but newer instruments have been validated with more diverse populations and sometimes account for education and age more systematically than the MMSE does. The broader trend in dementia diagnosis is toward multimodal assessment: combining cognitive testing with biomarker testing (blood tests for tau and amyloid, for example), imaging (MRI to look for atrophy), and functional assessment. This integrated approach is less vulnerable to false positives because cognitive impairment is confirmed by multiple independent measures. As these tools become more accessible and affordable, reliance on the MMSE as a stand-alone screening instrument is likely to decline—a positive development for reducing false positives and improving diagnostic accuracy.
Conclusion
The MMSE’s tendency to produce false positives is not a flaw in the test itself so much as a mismatch between how the test is used and what the test can reliably measure. Designed as a brief bedside screening instrument in the 1970s, it was never intended to be a diagnostic test, yet it has been deployed in primary care, community settings, and other contexts far from the specialized dementia clinics where it is most accurate. False-positive rates of 10-15% in community populations, and as high as 85% in some research studies, mean that many people are incorrectly identified as having cognitive impairment based on MMSE results alone.
If you are concerned about cognitive decline—your own or a family member’s—an MMSE score is a starting point for further evaluation, not a diagnosis. Request comprehensive neuropsychological testing, engage in detailed discussion about actual changes in daily functioning and memory, and seek evaluation from a cognitive specialist if the primary care evaluation is inconclusive. Understanding the MMSE’s limitations empowers you to interpret its results accurately, to avoid unnecessary alarm from false positives, and to pursue the more thorough assessment that dementia diagnosis truly requires.
Frequently Asked Questions
What does it mean if I score below 24 on the MMSE?
A score below 24 suggests possible cognitive impairment and warrants further evaluation, but it does not confirm dementia or cognitive impairment. Many people who score below 24 do not have any disease. Additional testing by a neuropsychologist or cognitive specialist is necessary to determine what, if anything, is wrong.
Can the MMSE be wrong even if my doctor says I failed it?
Yes. The MMSE has significant false-positive rates, especially in primary care settings and in people with limited education, lower literacy, or advanced age. Your doctor should not diagnose dementia based solely on MMSE results. A comprehensive evaluation is required.
How accurate is the MMSE really?
In memory clinic settings where patients have pre-existing cognitive concerns, the MMSE is moderately accurate, with sensitivity around 80% and specificity around 81%. In primary care and community populations, specificity is often 90% or better, but the positive predictive value is much lower—meaning false positives are common. Accuracy depends heavily on who is being tested and what the prior probability of disease is.
Does my education level affect my MMSE score?
Yes, significantly. People with less formal education tend to score lower on the MMSE, even if their cognition is normal. Some providers use education adjustments (adding back points based on education level) to account for this bias, but not all do. If you have limited education and received a low MMSE score, mention this to your doctor.
What test should I ask for instead of the MMSE?
If cognitive impairment is suspected, ask for neuropsychological testing (a comprehensive battery of tests administered by a psychologist) or alternatives like the Montreal Cognitive Assessment (MoCA) or Addenbrooke’s Cognitive Examination (ACE). These are more sensitive to mild impairment and less biased by education and age than the MMSE. You should also have imaging (MRI) and blood tests for biomarkers.
Can depression or anxiety cause a false positive on the MMSE?
Yes. Depression, anxiety, and other mood disorders can impair attention, memory, and processing speed in ways that lower MMSE scores, creating the appearance of cognitive impairment when the real problem is mood. This is one reason why comprehensive evaluation, including psychiatric assessment, is important.



